CompletedNot applicableNCT01897987

Follow-up Safety and Efficacy Evaluation on Subjects Who Completed PNEUMOSTEM® Phase-II Clinical Trial

Studying Bronchopulmonary dysplasia

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Medipost Co Ltd.
Principal Investigator
Wonsoon Park, MD, PhD
Department of Pediatrics, Samsung Medical Center
Intervention
Pneumostem®(biological)
Enrollment
62 enrolled
Eligibility
All sexes
Timeline
2014 – 2020

Study locations (2)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01897987 on ClinicalTrials.gov

Other trials for Bronchopulmonary dysplasia

Additional recruiting or active studies for the same condition.

See all trials for Bronchopulmonary dysplasia →

← Back to all trials